Yerevan
Tbilisi
Moscow
Paris
Los Angeles
Beijing
English
Հայերեն Русский
Main Timeline Video Share
May the Holiday Warm Hearts: Idram and IDBank Support the Children of Heroes Beneficiaries of the "By Your Side" program at IDBank AraratBank Named Large CSR Company of the Year Idram Joins the Fight Against Food Insecurity Ucom’s Renovated Sales and Service Center in Yerevan Mall Reopens 1% idcoin instead of New Year’s suffering: practical tips Idram Junior Donated Books to Schools Big Christmas Market with Idram, IDBank and idplus Ucom Supports Wildlife Monitoring in Ararat Region IDBank, Idram, and idplus at the Big Christmas Market Converse Bank Deputy CEO and CFO, Grant Akopian, Elected to BACEE Board Ucom and SunChild NGO Install a Solar Plant in Alaverdi Kindergarten
Timeline
IDBank at the UBA Regional Conference: From Travel Solutions to Business OpportunitiesJoint statement by the parties consolidatted around the national agenda35% Discount for the 35th Anniversary on Selected IDBank CardsConverse Bank Expands Its International Capabilities Through Cooperation with Citibank N.A.Business loan pre-approval in five minutes — what did Unibank showcase in Gyumri?Converse Bank Expands Its International Capabilities Through Cooperation with Citibank N.A.Bratislava forum to debate Armenia’s strategic future Ucom Service Center in Artashat Reopens at a New Address Ucom and Republican Union of Employers of Armenia Sign Cooperation MemorandumCreate your Visa Digital from Unibank for purchases and transfers Ucom – Main Sponsor of the 21st International Microelectronics Olympiad IDBank and Idram Hold Financial Literacy Session for Young Chess PlayersUcom Supports Silicon Mountains 2026, Driving Innovation and Technological Development IDBank has issued perpetual coupon bonds for the first timeIDBank Supports the Reconstruction of the Spandaryan Canal: Commemorative Plaque Dedicated to the Project SignedIDBank and Idram Presented Several Environmental Initiatives at COP17Ucom Shares Its Experience in Private Sector Engagement in Nature Conservation at COP17 Blue Zone«Here’s the screenshot, the money has been transferred»: IDBank warns of fake payment scamsFirst Steps in Your Career with IDBank: 16th Cycle of IDream LaunchedDigital Architecture for a Sustainable Future: IDBank's Article in Regional Post Magazine
All Timeline »
Life

1 in 4 people face side effects after getting COVID-19 vaccine

One in four people experiences side effects after being vaccinated against coronavirus. These are mostly minor side effects like pain at the injection site or headache, Lancet Infectious Diseases reported.

Analysis of data from the ZOE COVID Symptom Study, conducted by researchers at King's College London, found that side effects in the general population after vaccination with Pfizer and AstraZeneca were much lower than those reported in the trials.

The study also reported a significant reduction in infection rates from 12 to 21 days after the first dose of Pfizer (58% reduction) and AstraZeneca (39% reduction) compared to controls. The reduction in infection at least 21 days after the first dose is 69% for Pfizer and 60% for AstraZeneca.

Research has shown that:

  • 25.4% of vaccinated people reported one or more systemic side effects, while 66.2% reported one or more local side effects.
  • 13.5% of participants reported side effects after the first dose of Pfizer, 22.0% after the second dose of Pfizer, and 33.7% after the first dose of AstraZeneca.
  • The most common systemic side effect was a headache. 7.8% of people reported headaches after the first dose of Pfizer and 13.2% after the second dose of Pfizer. 22.8% of people who received the first dose of the AstraZeneca vaccine reported headaches.
  • The second most common systemic side effect was fatigue. 8.4% and 14.4% of participants reported fatigue after the first and second doses of the Pfizer vaccine, and 21.1% reported fatigue after the first dose of the AstraZeneca vaccine.
  • The most common localized side effect was soreness: 57.2% and 50.9% after the first and second doses of Pfizer vaccine and 49.3% after the first dose of AstraZeneca vaccine.

Side effects were more common in people under the age of 55 and in women.